These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Holloway RH; Dent J; Narielvala F; Mackinnon AM Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107 [TBL] [Abstract][Full Text] [Related]
3. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy. Klinkenberg-Knol EC; Meuwissen SG Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868 [TBL] [Abstract][Full Text] [Related]
4. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Lundell L Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020 [TBL] [Abstract][Full Text] [Related]
5. Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis. Zeitoun P Scand J Gastroenterol Suppl; 1989; 166():83-7; discussion 94. PubMed ID: 2690335 [TBL] [Abstract][Full Text] [Related]
6. Australian clinical trials of omeprazole in the management of reflux oesophagitis. Dent J Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019 [TBL] [Abstract][Full Text] [Related]
7. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study. Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778 [TBL] [Abstract][Full Text] [Related]
8. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777 [TBL] [Abstract][Full Text] [Related]
9. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161 [TBL] [Abstract][Full Text] [Related]
10. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912 [TBL] [Abstract][Full Text] [Related]
11. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Dehn TC; Shepherd HA; Colin-Jones D; Kettlewell MG; Carroll NJ Gut; 1990 May; 31(5):509-13. PubMed ID: 2190864 [TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709 [TBL] [Abstract][Full Text] [Related]
13. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G; Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305 [TBL] [Abstract][Full Text] [Related]
14. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease. Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123 [TBL] [Abstract][Full Text] [Related]
15. Review of esomeprazole in the treatment of acid disorders. Johnson DA Expert Opin Pharmacother; 2003 Feb; 4(2):253-64. PubMed ID: 12562316 [TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK. Wahlqvist P; Junghard O; Higgins A; Green J Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384 [TBL] [Abstract][Full Text] [Related]
17. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring. Ladas SD; Tassios PS; Raptis SA Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738 [TBL] [Abstract][Full Text] [Related]
18. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. Sharma P; Johnson DA; Monyak JT; Illueca M Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754 [TBL] [Abstract][Full Text] [Related]
19. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis. A study using 24 hour ambulatory pH and pressure monitoring. Timmer R; Breumelhof R; Nadorp JH; Smout AJ Gut; 1994 Nov; 35(11):1519-22. PubMed ID: 7828965 [TBL] [Abstract][Full Text] [Related]
20. [Omeprazole in the therapy of acid-induced diseases]. Simon B; Dammann HG; Müller P Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]